# Assessment of Early Outcomes of Roflumilast in Patients With Non Cystic Fibrosis Bronchiectasis

> **NCT04090294** · EARLY_PHASE1 · UNKNOWN · sponsor: **Assiut University** · enrollment: 35 (estimated)

## Conditions studied

- Bronchiectasis

## Interventions

- **DRUG:** Roflumilast

## Key facts

- **NCT ID:** NCT04090294
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-01
- **Primary completion:** 2020-09
- **Final completion:** 2020-11
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2019-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04090294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04090294, "Assessment of Early Outcomes of Roflumilast in Patients With Non Cystic Fibrosis Bronchiectasis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04090294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*